Alfonso
Calvo González
Catedrático de Universidad
National Cancer Institute
Rockville, Estados UnidosPublicaciones en colaboración con investigadores/as de National Cancer Institute (24)
2023
-
Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population
Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 411-418
2021
-
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Cancer Letters, Vol. 499, pp. 279-289
2010
-
Molecular characterization of the Gγ-globin-tagtransgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer
Prostate, Vol. 70, Núm. 6, pp. 630-645
-
VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop
Experimental Cell Research, Vol. 316, Núm. 4, pp. 554-567
2008
-
Human adrenomedullin up-regulates interleukin-13 receptor α2 chain in prostate cancer in vitro and in vivo: A novel approach to sensitize prostate cancer to anticancer therapy
Cancer Research, Vol. 68, Núm. 22, pp. 9311-9317
-
Identification of VEGF-regulated genes associated with increased lung metastatic potential: Functional involvement of tenascin-C in tumor growth and lung metastasis
Oncogene, Vol. 27, Núm. 40, pp. 5373-5384
2007
-
2-Methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: Molecular distinctions from the mammary gland of pregnant mice
Endocrinology, Vol. 148, Núm. 3, pp. 1266-1277
-
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis
International Journal of Cancer, Vol. 120, Núm. 10, pp. 2096-2109
2006
-
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression
Cancer Research, Vol. 66, Núm. 7, pp. 3495-3503
2005
-
Gene expression profiling identifies IL-13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin
International Journal of Cancer, Vol. 114, Núm. 6, pp. 870-878
-
Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms
Oncogene, Vol. 24, Núm. 5, pp. 790-800
-
Prostate cancer and the genomic revolution: Advances using microarray analyses
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 576, Núm. 1-2, pp. 66-79
2004
-
Application of Gene Expression Profiling for Validating Models of Human Breast Cancer
Toxicologic Pathology, Vol. 32, Núm. SUPPL. 1, pp. 84-89
-
Genomic Approaches to Understanding Mammary Tumor Progression in Transgenic Mice and Responses to Therapy
Clinical Cancer Research
2003
-
Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo
Molecular and Cellular Endocrinology, Vol. 199, Núm. 1-2, pp. 179-187
2002
-
Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice
Cancer Research, Vol. 62, Núm. 14, pp. 3934-3938
-
Adrenomedullin and proadrenomedullin N-terminal 20 peptide in the normal prostate and in prostate carcinoma
Microscopy Research and Technique, Vol. 57, Núm. 2, pp. 98-104
-
Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors
Cancer Research, Vol. 62, Núm. 18, pp. 5325-5335
-
Chipping away at breast cancer: Insights from microarray studies of human and mouse mammary cancer
Endocrine-Related Cancer, Vol. 9, Núm. 4, pp. 207-220
-
Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin
International Journal of Cancer, Vol. 101, Núm. 3, pp. 224-234